PI
-
Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia (Circulation. (2024) 149 (343–353) DOI: 10.1161/CIRCULATIONAHA.123.065529)
Wiegman, A., Greber-Platzer, S., Ali, S., Doortje Reijman, M., Brinton, E. A., Charng, M.-J., Srinivasan, S., Baker-Smith, C., Baum, S., Brothers, J. A., Hartz, J., Moriarty, P. M., Mendell, J., Bihorel, S. B., Banerjee, P., George, R. T., Hirshberg, B. & Pordy, R., 8 Jul 2025, In: Circulation. 152, 1, p. e22Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
The Brussels International Declaration on Lipoprotein(a) Testing and Management
Kronenberg, F., Bedlington, N., Ademi, Z., Geantă, M., Silberzahn, T., Rijken, M., Kaal, A., Harada-Shiba, M., Chen, Z., Thanassoulis, G., Eliasen, B., Eiselé, J.-L., Wiegman, A., Ballantyne, C. M., Broome, E., Calabrò, M., Corral, P., Dol, A., Donato, L. J. & Evans, E. & 20 others, , Jul 2025, In: Atherosclerosis. 406, 119218.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficacy and Safety of Inclisiran in Adolescents with Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results from the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial
Wiegman, A., Peterson, A. L., Hegele, R. A., Bruckert, E., Schweizer, A., Lesogor, A., Wang, Y. & Defesche, J., 24 Jun 2025, In: Circulation. 151, 25, p. 1758-1766 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications